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Aim
The propagation of HIV-1 infection represents a major
problem of public health, notably in sub-Saharan Africa
where about six out of ten infected adults are women.
Among the new options of preventive therapy, antiretro-
viral drugs used as microbicides distributed via an intra-
vaginal ring (IVR) constitutes an original solution. IVR
is an interesting mode of drug delivery because it is a
coit-independent device that can be left in the vagina
for several months and can release regular amounts of
microbicides. The aim of this work was to set up a sili-
cone IVR able to deliver simultaneously several drugs
with the precise objective of determining if the release
of each drug is possible with the used silicones and of
choosing the best formulation.
Materials and methods
IVRs were made manually with siloxanes combining two
elastomers from Blue Star Silicone before and after reticu-
lation, and were loaded with different concentrations of
tenofovir. The rings were then placed under conditions
mimicking closely the physiological environment of the
vagina. The amounts of released tenofovir were measured
by UV spectrophotometry.
Results
The manual mode of fabrication of IVR is described with
details. Different combinations of siloxanes were used.
Only some of them were shown to release amounts of
tenofovir that can be considered as efficient for protecting
from a heterosexual HIV-1 infection. We present rheologi-
cal analyses that sustain these differences.
Conclusions
We propose a model that was shown able to test the
release of antiretroviral drugs by a silicone multi-reservoir
IVR under various experimental conditions. The release of
tenofovir by silicone obeys to physico-chemical rules that
we tried to elucidate. The study of other antiretroviral
drugs is ongoing with the aim of developing a device able
to protect efficiently against the viral loads observed in
semen. At term, this system could be rendered more com-
plex by the addition of antiviral compounds directed
against other viruses and/or of anti-inflammatory drugs or
hormones.
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